Key Segmentation
By Service Type
-
Biomarker Services
-
Genetic and Genomic Services
-
Safety Testing
-
Anatomic Pathology and Histology
-
Microbiology and Virology
-
Specimen Management and Storage
By Therapeutic Area
-
Oncology
-
Neurology
-
Cardiology
-
Infectious Diseases
-
Others
By Clinical Trial Phase
-
Phase I
-
Phase II
-
Phase III
-
Phase IV
By End User
-
Pharmaceutical Companies
-
Biotechnology Companies
-
Contract Research Organizations
-
Medical Device Companies
-
Academic and Research Institutes
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market was valued at USD 4.57 Billion in 2025 and is estimated at USD 4.85 Billion in 2026. It is projected to reach USD 8.28 Billion by 2035.
North America led with a 39.46% share in 2025. Asia Pacific is the fastest-growing region, with a CAGR of 7.66% from 2026 to 2035.
The market is projected to expand at a CAGR of 6.12% from 2026 to 2035.
Biomarker services, oncology, Phase III studies, and pharmaceutical companies lead their axes. Genetic and genomic services, neurology, Phase II studies, and biotechnology companies grow fastest.
Labcorp, IQVIA Laboratories, ICON Central Laboratories, Eurofins Central Laboratory, and Medpace are the best-documented providers.